Peptide Research & Optimization

The Science of
Self-Optimization

Evidence-based insights into peptide protocols, safety research, and optimization strategies. Built on clinical rigor, powered by community knowledge.

Stay Ahead of the Research

Get weekly insights on peptide protocols, safety updates, and optimization strategies delivered to your inbox.

No spam. Unsubscribe anytime. Clinical rigor, always.

Evidence-based insights into peptide outcomes, safety research, and optimization strategies.

Research

Outcome Guides
Peptide Profiles
Companions
Research Articles
TRT+ Profiles

Site

Home
Categories
RSS Feed
Dashboard

Legal

Privacy Policy
Terms of Service
Contact

A pinned.life project

Peptide Research & Optimization

The Science of
Self-Optimization

Evidence-based insights into peptide protocols, safety research, and optimization strategies. Built on clinical rigor, powered by community knowledge.

35+

Articles

Research Articles

Deep dives into peptide science — evidence-graded, honestly reported

All Peptide Tracker Apps in 2026: What We Found When We Tested Them All FDA Peptide Reclassification 2026: What's Changing, What's Not, and What It Means for Your Protocol You're Running Peptides Blind. Here's What That's Actually Costing You.The Peptide Blend Lie: Fixed Ratios Don't Work for Every Body Inside KLOW: What's Actually in the Most Popular Peptide Blend

ResearchArticle

New

Peptide Tracker Apps in 2026: What We Found When We Tested Them All

We tested every peptide tracker app in 2026. Here's what we found, including where our competitors beat us.

The peptide tracker market went from empty to 15+ apps in 12 months. We tested them all and scored them on what matters: safety features, PK modelling, multi-compound support, and price. Pinned is ours. We're transparent about that.

Peptide Profiles

Detailed compound profiles with mechanisms, safety data, and dosing protocols

All FOXO4-DRI Ipamorelin

Stay Ahead of the Research

Get weekly insights on peptide protocols, safety updates, and optimization strategies delivered to your inbox.

No spam. Unsubscribe anytime. Clinical rigor, always.

pin.board — The Science of Self-Optimization

Research Articles

Deep dives into peptide science — evidence-graded, honestly reported

ResearchArticle

New

Peptide Tracker Apps in 2026: What We Found When We Tested Them All

We tested every peptide tracker app in 2026. Here's what we found, including where our competitors beat us.

Peptide Profiles

Detailed compound profiles with mechanisms, safety data, and dosing protocols

All FOXO4-DRI Ipamorelin

All Muscle Growth Fat Loss Injury Repair Bone Health

peptide trackerapp comparisonpinnedregimensafety engine+2

FDA Peptide Reclassification 2026: What's Changing, What's Not, and What It Means for Your Protocol

ResearchArticle

New

FDA Peptide Reclassification 2026: What's Changing, What's Not, and What It Means for Your Protocol

RFK said peptides are back. The FDA hasn't published the rule change yet. Here's what's actually happening.

The FDA's 2026 peptide reclassification is a regulatory process, not a completed rule change. Seven compounds face PCAC review in July 2026, legal access requires a prescription, and the grey market remains unchanged until the FDA publishes.

fdapeptide reclassificationregulationbpc-157tb-500+2

ResearchArticle

You're Running Peptides Blind. Here's What That's Actually Costing You.

You're spending $200–500/month on biological software and tracking it in a Notes app. The compounds aren't the problem. The total absence of protocol discipline is.

Peptide access exploded in 2026. Protocol discipline didn't follow. Most users are dosing from Reddit consensus, ignoring half-lives, missing timing windows, and running zero safety baselines. This article maps the specific failure modes, the insulin trap, the NO floor, the receptor ceiling, the sedentary trap, and what precision tracking actually looks like by comparison.

peptide-protocolspharmacokineticsbpc-157cjc-1295ipamorelin+9

ResearchArticle

The Peptide Blend Lie: Fixed Ratios Don't Work for Every Body

Fixed-ratio peptide blends promise synergy in a single vial — but pharmacokinetics, missing human data, and one-size-fits-all dosing tell a different story.

From BPC/TB duos to quad stacks, we examine why pre-mixed peptide blends fail the precision medicine test — mismatched half-lives, untested combinations, and the convenience tax you're actually paying.

peptide blendsfixed ratiospharmacokineticsBPC-157TB-500+4

ResearchArticle

Inside KLOW: What's Actually in the Most Popular Peptide Blend

A research-driven breakdown of what's actually inside the most popular peptide blend — and why fixed ratios create pharmacological problems your supplier won't mention.

Inside the KLOW quad stack: GHK-Cu, BPC-157, TB-500, and KPV. We examine the pharmacokinetic mismatches, the missing human trials, and why individual titration beats fixed-ratio convenience.

KLOWBPC-157TB-500GHK-CuKPV+2

Selank

A tuftsin-derived heptapeptide that delivers benzodiazepine-level anxiety relief without sedation, dependence, or cognitive fog — while simultaneously boosting immune defence.

Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) engineered from the immune peptide tuftsin. It allosterically modulates GABA-A receptors, stabilises endogenous enkephalins, and upregulates BDNF — delivering anxiolysis, cognitive enhancement, and immunomodulation in a single molecule.

selankneuroprotectionanxiolyticnootropictuftsin+5

Strength & Performance

Cardiovascular Health

Supplements